Who are the major cell line development industry players?

Advanced Instruments, LLC, Aragen Life Sciences Ltd., ASIMOV, Cytiva (Danaher Corporation), Eurofins Scientific, Fyonibio, GensSript Biotech, and Lonza Group AG among others.

Why is the cell line development industry growing in North America?

North America cell line development market secured 34.3% share in 2023 and will expand rapidly through 2032, driven by huge patient base prone to infectious and chronic diseases.

How much is the cell line development industry worth?

The cell line development market was valued at USD 5.8 billion in 2023 and will grow at 10.3% CAGR during 2024-2032, driven by the global prevalence of cancer owing to adoption of sedentary lifestyles.

Why is the demand for cell line development reagents & media rising?

The reagents & media segment of the market recorded USD 2.6 billion in 2023 and will grow through 2032, driven by recurring demand for media and reagents during the cell line development process.

Cell Line Development Market Share

Report ID: GMI429

Published Date: July 2024

Report Format: PDF

Download Free PDF

Cell Line Development Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical & biotechnology companies that manufacture cell line development products vying for market share. Key players are engaging in strategic initiatives such as collaboration, product launch, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for cell line development.

Cell Line Development Market Companies

Prominent players operating in the cell line development industry are as mentioned below:

Advanced Instruments, LLC
Aragen Life Sciences Ltd.
ASIMOV
Cytiva (Danaher Corporation)
Eurofins Scientific
Fyonibio
GensSript Biotech
Lonza Group AG
Novartis AG
ProBioGen
PromoCell
Sartorius AG
Sigma Aldrich (Merck KGaA)
Thermo Fisher Scientific Inc.
WuXi AppTec

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Question(FAQ) :

Who are the major cell line development industry players?: Advanced Instruments, LLC, Aragen Life Sciences Ltd., ASIMOV, Cytiva (Danaher Corporation), Eurofins Scientific, Fyonibio, GensSript Biotech, and Lonza Group AG among others.
Why is the cell line development industry growing in North America?: North America cell line development market secured 34.3% share in 2023 and will expand rapidly through 2032, driven by huge patient base prone to infectious and chronic diseases.
How much is the cell line development industry worth?: The cell line development market was valued at USD 5.8 billion in 2023 and will grow at 10.3% CAGR during 2024-2032, driven by the global prevalence of cancer owing to adoption of sedentary lifestyles.
Why is the demand for cell line development reagents & media rising?: The reagents & media segment of the market recorded USD 2.6 billion in 2023 and will grow through 2032, driven by recurring demand for media and reagents during the cell line development process.

Related Reports

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Buy now

Premium Report Details

Base Year: 2023

Companies covered: 15

Tables & Figures: 355

Countries covered: 22

Pages: 218

Download Free PDF

Cell Line Development Market Share

Cell Line Development Market Share

Cell Line Development Market Companies

Premium Report Details

Industries

Information

Link

Global Headquarters